Literature DB >> 6796284

Changes in toxic and antitumor properties of ftorafur by induction or inhibition of the microsomal enzymes activity.

G A Belitsky, V M Bukhman, I A Konopleva.   

Abstract

The inducers of microsomal drug-metabolizing enzymes phenobarbital (PB) and 20-methylcholanthrene (MC) inhibited the lethargic effect of high doses of ftorafur in C57BL/6j mice, but stimulated the animal mortality at days 4-8 after the drug administration. The opposite effect has been obtained by the combination of ftorafur with the inhibitor of the microsomal enzymes SKF 525A. Animal pretreatment with PB or with PB + MC markedly enhanced the antineoplastic activity of ftorafur in Rauscher leukemia-, leukemia La-, or hemangiopericytoma-bearing mice but seemed unlikely to afford any therapeutic advantage over this drug because the lethal toxicity of ftorafur was increased.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796284     DOI: 10.1007/BF00262340

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  15 in total

1.  STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. 3. AN IN VIVO ASSAY FOR ANTI-VIRAL AGENTS.

Authors:  M A CHIRIGOS
Journal:  Cancer Res       Date:  1964-07       Impact factor: 12.701

2.  [Transplantable cancer of the urinary bladder and hemangiopericytoma obtained by means of the ectopic transplantation of tissues of the fetal urinary bladder].

Authors:  G Ia Svet-Moldavskiĭ; V A Turusov; T V Osipova
Journal:  Vopr Onkol       Date:  1975

3.  The disposition of ftorafur in rats after intravenous administration.

Authors:  A M Cohen
Journal:  Drug Metab Dispos       Date:  1975 Jul-Aug       Impact factor: 3.922

4.  Intermittent high single-dose ftorafur: phase I clinical trial with a pharmacologic-toxicity correlation.

Authors:  S W Hall; M Valdivieso; R S Benjamin
Journal:  Cancer Treat Rep       Date:  1977-11

5.  Comparison of the effects of 5-fluorouracil and Ftorafur on the haematopoiesis in mice.

Authors:  I Hrsak; S Pavicić
Journal:  Biomedicine       Date:  1974-04-10

6.  To biological activity of antitumour antimetabolite "ftorafur".

Authors:  A Z Smolyanskaya; O A Tugarinov
Journal:  Neoplasma       Date:  1972       Impact factor: 2.575

7.  Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.

Authors:  J A Benvenuto; K Lu; S W Hall; R S Benjamin; T L Loo
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

8.  Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice.

Authors:  R K Johnson; B T Garibjanian; D P Houchens; I Kline; M R Gaston; A B Syrkin; A Goldin
Journal:  Cancer Treat Rep       Date:  1976-09

9.  Synthesis and biological activities of ftorafur metabolites. 3'- and 4'-hydroxyftorafur.

Authors:  A J Lin; R S Benjamin; P N Rao; T L Loo
Journal:  J Med Chem       Date:  1979-09       Impact factor: 7.446

10.  5-Fluorouracil concentrations in human plasma following R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) administration.

Authors:  J L Au; W Sadée
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

View more
  1 in total

1.  Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study.

Authors:  S Palmeri; V Gebbia; A Russo; M G Armata; N Gebbia; L Rausa
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.